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Background: It is difficult to diagnose spontaneous bacterial peritonitis (SBP) early in decompensated liver cirrhotic
ascites patients (DCPs). The aim of the study was to measure serum procalcitonin (PCT) levels and peripheral blood
leukocyte/platelet (WBC/PLT) ratios to obtain an early diagnostic indication of SBP in DCPs.
Methods: Our cohort of 129 patients included 112 DCPs (94 of whom had infections) and 17 cases with
compensated cirrhosis as controls. Bacterial cultures, ascitic fluid (AF) leukocyte and peripheral WBC/PLT counts,
and serum PCT measurements at admission were carried out prior to the use of antibiotics. Receiver operating
characteristic (ROC) curves were generated to test the accuracies and cut-off values for different inflammatory
markers.
Results: Among the 94 infected patients, 66 tested positive by bacterial culture, for which the positivity of blood,
ascites and other secretions were 25.8%, 30.3% and 43.9%, respectively. Lung infection, SBP and unknown sites of
infection accounted for 8.5%, 64.9% and 26.6% of the cases, respectively. Serum PCT levels (3.02 ± 3.30 ng/mL) in
DCPs with infections were significantly higher than those in control patients (0.15 ± 0.08 ng/mL); p < 0.05. We used
PCT ≥0.5 ng/mL as a cut-off value to diagnose infections, for which the sensitivity and specificity was 92.5% and 77.1%.
The area under the curve (AUC) was 0.89 (95% confidence interval: 0.84–0.91). The sensitivity and specificity were
62.8% and 94.2% for the diagnosis of infections, and were 68.8% and 94.2% for the diagnosis of SBP in DCPs when
PCT ≥2 ng/mL was used as a cut-off value. For the combined PCT and WBC/PLT measurements, the sensitivity was
76.8% and 83.6% for the diagnosis of infections or SBP in DCPs, respectively.
Conclusion: Serum PCT levels alone or in combination with WBC/PLT measurements seem to provide a satisfactory
early diagnostic biomarker in DCPs with infections, especially for patients with SBP.
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One of the most common and serious complications in
decompensated cirrhotic patients (DCPs) is bacterial in-
fection [1-3]. Bacterial infections are known to be import-
ant causes of high mortality and morbidity in such
patients, although antibiotics have been developed in re-
cent decades [4]. Therefore, it has been suggested that the
occurrence of bacterial infections should be considered as
a further prognostic stage to define critical cirrhosis,
which is associated with >40% increased mortality and
longer hospital stays [2,5]. The most common infections
in DCPs are cases of spontaneous bacterial peritonitis
(SBP), which account for 40%–70% of cases, followed by
urinary tract infections, pneumonia and cellulitis [3,6].
The early diagnosis of infections can improve the progno-
ses of patients [7]. However, it is difficult to diagnose SBP
early in DCPs with ascites because the clinical manifesta-
tions and ascitic biochemical characteristics are often in-
consistent [3-6]. Current guidelines state that culture
positivity for a pathogen in ascitic fluid (AF) is the gold
standard for the diagnosis of SBP. However, ascites culture
has been negative in about 60% of patients with clinical
manifestations suggestive of SBP and increased ascites
neutrophil count [8,9]. Therefore, new studies of early
diagnosis, prevention and treatment are needed to im-
prove clinical outcomes. Many studies have shown that
serum procalcitonin (PCT) is a sensitive biomarker that
can be used to monitor bacterial infections, and measure-
ments of PCT levels may guide the clinical use of antibi-
otics [10]. However, the diagnostic value of serum PCT
levels in DCPs with infections [11], especially SBP, remains
unclear, several studies provide conflicting results [12-16].
Therefore, this study aimed to determine the diagnostic
value of serum PCT levels alone, or in combination with
the peripheral blood leukocyte and platelet count (WBC/Table 1 Clinical characteristics of the enrolled patients
DCPs with infection
Age (M ± SD) 59.84 ± 11.68
Gender (%) Male 58 (61.7)
Female 36 (38.3)
Etiology of cirrhosis (%) Hepatitis B 52 (55.3)
Hepatitis C 2 (2.1)
Alcohol 21 (22.3)
Others 19 (20.3)
Child–Pugh classification (%) A 0 (0)
B 5 (5.3)
C 89 (94.7)
Number of complications (%)* ≥2 66 (70.2)
<2 28 (29.8)




This was a retrospective cross-sectional case-controlled
study to determine the early diagnostic value of serum PCT
levels alone, or in combination with WBC/PLT measure-
ments in DCPs with SBP.
Patients
A cohort of 129 patients included 112 DCPs and 17 age-
and sex-matched compensated cirrhosis controls who
were enrolled for retrospective studies at the Depart-
ment of Gastroenterology and Hepatology in Beijing
You’an Hospital affiliated to Capital Medical University
between January 2011 and June 2013 (Table 1). All sub-
jects met the following criteria: (1) decompensated liver
cirrhosis with ascites and/or other complications were
confirmed by medical history, liver function assessments
and B ultrasonography (LOGIQ9, General Electric, Fair-
field, USA) or computerized tomography (CT; GE HIS-
PEED DXI, General Electric) examinations were proven
cirrhosis; (2) the compensated cirrhosis was histologi-
cally diagnosed or peripheral PLT was <100 × 109/L
and liver elastography stiffness was >12.5 kPa by
FibroScan®502 (ECHOSENS, French); (3) the pathogen
cultures, serum PCT measurements, blood and AF bio-
chemistry tests and peripheral WBC/PLT counts were
conducted before the use of antibiotics at admission;
and (4) the patients did not exhibit liver failure, liver
cancer or fungal infection or show serious heart, lung,
or brain insufficiency, or have a mental illness.
The etiology of cirrhosis was determined in cirrhotic pa-
tients by assessing hepatitis B and C status, alcoholism,s N = 94 DCPs without infections N = 18 Control N = 17
56.44 ± 12.4 54.05 ± 10.24
13 (72.2) 11 (64.7)
5 (27.8) 6 (35.3)
13 (72.2) 13 (76.5)
0 (0) 0 (0)
5 (27.8) 4 (23.5)
0 (0) 0 (0)
0 (0) 17 (100)
7 (38.9) 0 (0)
11 (61.1) 0 (0)
8 (44.4) 0 (0)
10 (55.6) 0 (0)
encephalopathy or hepatorenal syndrome.
Table 2 Serum PCT levels, peripheral blood WBC and
WBC/PLT ratios in the enrolled subjects
Group PCT (ng/mL) WBC (×109/L) WBC/PLT
SBP (n = 61) 3.55 ± 3.53* 8.8 ± 1.1 0.23 ± 0.03*
Lung infection (n = 8) 3.2 ± 3.46* 6.7 ± 2.3 0.17 ± 0.06*
Unknown infections (n = 25) 2.24 ± 2.73* 5.1 ± 1.1 0.35 ± 0.07*
Control (n = 17) 0.15 ± 0.08 5.14 ± 1.04 0.05 ± 0.2
*Compared with control; p < 0.001.
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medical record of each patient. The severity of cirrhosis was
classified based on the Child–Pugh criteria, while all of the
cirrhotic patients were evaluated for the presence of hepato-
cellular carcinoma using B ultrasonography and CT.
The study was approved by the Clinical Research and
Ethics Committee of Capital Medical University, Beijing
You’an Hospital.
Paracentesis and AF culture
Diagnostic paracentesis was carried out at the bedside
using a sterile method with a 22-G needle attached to a
20-cc syringe after local anesthesia with lidocaine. AF was
immediately drawn from the peritoneal fluid after the ster-
ile needle was attached to a syringe for paracentesis. Then,
aspirated AF was collected into ethylenediaminetetraacetic
acid tubes and analyzed for biochemistry and leukocyte
counts within 3 h. We collected 10 mL AF from patients
and cultured it in aerobic blood culture bottles (Becton
Dickinson, Franklin Lakes, NJ, USA). These bottles were
then placed into an automated Bactec 9120 3D culture
system (Becton Dickinson) for 48–72 h. Bacterial identifi-
cation and antimicrobial susceptibility testing were carried
out using standard procedures with a Phoenix100 auto-
mated bacterial identification system.
Bacterial culture of other samples
We inoculated 10 mL venous blood, urine or respiratory se-
cretion samples taken from patients before the administra-
tion of antibiotics in blood culture bottles using the same
methods as described above for the ascites bacterial culture.
Diagnostic criteria of infections
Bacterial infections in DCPs met sepsis and/or SBP cri-
teria. Sepsis was determined by the following criteria: (1)
fever (T >38°C); (2) peripheral WBC >10 × 109/L; and (3)
unexplained circulatory or renal failure and systolic blood
pressure <90 mmHg after fluid resuscitation. Pneumonia
was confirmed by lung X-ray and CT examination. Urin-
ary tract infections were confirmed by positive urine bac-
terial cultures.
Diagnostic criteria of SBP
SBP was determined based on one of the following cri-
teria, as revised from available guidelines [8,9]: (1) abdom-
inal pain and/or fever (T >37.5°C), and/or abdominal and
rebound tenderness (excluding secondary peritonitis); and
(2) AF leukocytes counts ≥250/mm3 and/or bacterial cul-
ture positivity.
Serum PCT measurements
Serum PCT levels were measured using enzyme-linked
fluorescence analysis (ELFA) with a detection limit of0.1 ng/mL using an automated enzyme-linked fluores-
cence quantitative analyzer (VIDAS, Merieux, France).
Assessments of blood biochemistry
Data from blood biochemistry tests were obtained from the
medical records of each patient. These data included periph-
eral WBC/PLT counts (determined using a MEK 6318 K
automatic blood cell analyzer, Nihon Kokden, Tokyo, Japan)
and parameters from liver and renal biochemical profiles,
such as alanine aminotransferase, aspartate aminotransfer-
ase, total bilirubin, albumin, blood urea nitrogen, and cre-
atinine levels (as measured using an automatic biochemical
analyzer, Olympus AU640, Tokyo, Japan).
Statistical analyses
Qualitative data were expressed as n (%) and quantitative
variables were expressed as the mean ± standard devi-
ation (M ± SD). The Mann–Whitney U test was used to
compare non-normally distributed quantitative data, and
Pearson’s χ2 test was used to evaluate qualitative data.
Statistical tests were performed using computer software
(SPSS16.0, SPSS Inc. Chicago, IL, USA). The receiver
operating characteristic (ROC) curves were generated to
test the accuracies and cut-off values for different in-
flammatory markers. The optimal cutoff value of WBC/
PLT was determined by calculating the point on the
ROC curve with the maximum Youden index (sensitiv-
ity-[1-specificity]). While the cutoff values of WBC and
PCT were determined according to the standard widely
accepted in clinic [12-18]. The area under the curve
(AUC) and 95% confidence interval (CI) were assessed
where appropriate. A level for statistical significance was
set at p < 0.05.
Results
Patient demographics
A total 94 of 112 DCPs had confirmed bacterial infec-
tions. These patients included 8 cases with lung infec-
tion (8.5%), 61 cases with SBP (64.9%) and 25 cases with
an unknown site of infection (26.6%). A total of 66 of 94
infection cases showed bacterial culture positivity. The
bacterial culture positivity rate of blood, AF and other
secretion samples was 25.8% (17/66), 30.3% (20/66) and
43.9% (29/66), respectively. Among 61 DCPs with SBP,
Figure 1 Receiver operating characteristic (ROC) curves for PCT,
WBC/PLT and WBC for diagnosis of infection in cirrhotic patients.
AUCs were 0.89 (95% CI: 0.84-0.91), 0.8 (95% CI: 0.72- 0.82 ) and 0.73
(95% CI: 0.64-0 .81) for PCT, WBC/PLT and WBC, respectively. The
sensitivity ,specificity, PPV and NPV were 92.5%, 77.1%, 91.5%, and
79.4% at the cutoff of 0.5 ng/ml for PCT, 39.6%, 100%, 100%, and 38.1%
at 0.25 for WBC/PLT, and 47.8%,100%,100% and 41.6% at 1.0 × 109/L
for WBC. FPR=false positive rate (1- specificity), TPR= true positive rate
(sensitivity), AUC= area under curve, CI = confidence interval,
PPV=positive predictive value, NPV=negative predictive value.
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percent (66/94) of DCPs with infections had at least two
kinds of complications, including ascites, esophageal
variceal bleeding, hepatic encephalopathy or hepatorenal
syndrome.
The diagnostic value of serum PCT levels and WBC/PLT
ratios for detecting infections
Serum PCT levels (3.02 ± 3.30 ng/mL) in DCPs with in-
fections were significantly higher than in control patients
(0.15 ± 0.08 ng/mL); p < 0.05. There were no significant
differences between serum PCT and WBC/PLT in cir-
rhotic patients with different sites of infection (Table 2).
In peripheral blood, WBC ≥10 × 109/L and WBC/PLT ≥0.25
was used as a cut-off to diagnose infections in DCPs, for
which the AUC was 0.73 (95% CI: 0.64–0.81) and 0.8
(95% CI: 0.72–0.82), respectively (Figure 1). The cut-off
value for serum PCT levels was 0.5 ng/mL for the diag-
nosis of infections in DCPs, for which the sensitivity
and specificity were 92.5% and 77.1%, respectively. TheTable 3 The diagnostic efficacy of serum PCT levels combined
Group PCT
≥2 ng/mL
Infected (n = 94) 59
Non-infected (n = 35) 2
Sensitivity (%) 62.8
Specificity (%) 94.2
Positive predictive value (PPV, %) 96.7
Negative predictive value (NPV, %) 48.5AUC was 0.89 (95% CI: 0.84–0.91; Figure 1). The com-
bination of serum PCT levels (cut-off: 2.0 ng/ml) and
WBC/PLT ratios (≥0.25) can significantly improve sen-
sitivity for the early diagnosis of infections in DCPs
(Table 3).
The diagnostic value of serum PCT levels and WBC/PLT
ratios for SBP
There were no significant differences in serum PCT
levels or the WBC/PLT ratio between in AF culture-
positive (2.92 ± 2.87 ng/mL, 0.25 ± 0.05) and culture-
negative (2.88 ± 3.29 ng/mL, 0.23 ± 0.36) DCPs with SBP;
p > 0.05. The diagnostic cut-off values for serum PCT
levels (≥2.0 ng/mL), WBC (≥10 × 109/L) and WBC/PLT
(≥0.25) are shown in Figure 2, for which the AUC was
0.89 (95% CI: 0.82–0.97), 0.79 (95% CI: 0.61–0.87), and
0.73 (95% CI: 0.61–0.82), respectively. The combination
of serum PCT levels and the WBC/PLT ratio could sig-
nificantly improve sensitivity for the early diagnosis of
SBP in DCPs (Table 4).
Discussion
Liver cirrhosis patients are very susceptible to bacterial
infections because of acquired immune defects of both
humoral and cell-mediated immunity and bacterial
translocation [3,19]. Liver dysfunction is strongly associ-
ated with impaired defenses against bacteria, and with
structural and functional alterations in the intestinal mu-
cosa that lead to an increase in the permeability to bac-
teria and bacteria-derived products, which worsens over
time and with disease progression. In end-stage liver dis-
ease patients, these events favor the translocation of
bacteria, which increases susceptibility to infections, par-
ticularly SBP. The release of inflammatory mediators
during infections leads to systemic, renal and hepatic
hemodynamic impairment, which dramatically affects
the prognosis, even after infections resolve [1,3]. More
than 70% mortality in cirrhotic patients with drug-
resistant infections was also reported [7,20]. It has been
suggested that the early diagnosis of SBP, along with the
prompt initiation of empirically based antibiotic therapy,
have been considered to be crucial for the survival of awith WBC/PLT ratios for infections in cirrhotic patients
PCT +WBC/PLT







Figure 2 Receiver operating characteristic (ROC) curves for PCT,
WBC/PLT and WBC for diagnosis of SBP in cirrhotic patients. AUCs
were 0.89 (95% CI: 0.82-0.97), 0.79 (95% CI: 0.61-0 .87), and 0.73 (95% CI:
0.61-0.82), for PCT, WBC/PLT and WBC, respectively. The sensitivity ,
specificity, PPV and NPV were 68.8%, 94.2%, 95.4%, and 63.5% at the
cutoff of 2 ng/ml for PCT, 30.0%, 100%, 100%, and 47.9% at 0.25 for
WBC/PLT, and 44.3%, 100%, 100%, and 50.7% at 1.0 × 109/L for WBC.
FPR=false positive rate (1- specificity), TPR= true positive rate
(sensitivity), AUC= area under curve, CI = confidence interval,
PPV=positive predictive value, NPV=negative predictive value.
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lung, urinary tract or skin infections were easy to diag-
nose clinically. To date, it remains a challenge for clini-
cians to arrive at an early diagnosis of SBP in cirrhotic
patients with ascites because the early symptoms and
signs are not obvious [5]. Biomarkers with high sensitiv-
ity and specificity for the diagnosis of SBP are lacking.
The diagnosis of SBP was based on AF polymorpho-
nuclear (PMN) leukocyte counts >250/mm3 and positive
bacterial cultures without any evidence of an external or
intra-abdominal source of infection or malignancy ac-
cording to all of the available guidelines [8,9]. However,
on the one hand, despite the use of sensitive pathogen
culture methods, ascites culture has been negative in as
many as 60% of patients with clinical manifestations sug-
gestive of SBP and with increased ascites neutrophilTable 4 The diagnostic efficacy of serum PCT levels combined
Group PCT
≥2 ng/mL
SBP (n = 61) 42
Non-infected (n = 35) 2
Sensitivity (%) 68.8
Specificity (%) 94.2
Positive predictive value (PPV, %) 95.4
Negative predictive value (NPV, %) 63.5leukocyte counts [21,22]. On the other hand, performing
an AF culture is time consuming and is not always an
available option in an emergency. Therefore, the discov-
ery of easy to use, rapid and reliable diagnostic bio-
markers for SBP in DCPs was needed.
Levels of PCT, a propeptide of calcitonin with a long
half-life of 25–30 h that is produced by peripheral blood
mononuclear cells, significantly increases during the sys-
temic response of an organism to an infection and has
been hailed as a novel inflammatory biomarker for bac-
terial infections [23-25]. In more severe infections,
higher serum PCT levels were observed. The specificity
of PCT for the diagnosis of severe sepsis and septic
shock is 100%, and was suggested to warn of the occur-
rence of multiple organ dysfunction [18,25]. Serum PCT
measurements have been reported to be superior to C-
reactive protein in discriminating infectious from other
inflammatory diseases, such as acute pancreatitis, car-
diogenic shock and acute transplant rejection [26,27].
Meanwhile, serum PCT can be rapidly and easily de-
tected as early diagnostic biomarker for sepsis [23].
However, the utility of PCT as a marker for the early
diagnosis of SBP has been reported limitedly, with con-
flicting results [12-16].
In this study, we found that serum PCT levels in cir-
rhotic patients with infections at admission were signifi-
cantly higher than in non-infected patients and showed
no relationship with the site of infection. Based on a
serum PCT cut-off value of 0.5 ng/mL for the diagnosis
of infections, the sensitivity and specificity were 92.5%
and 77.1%, respectively. Based on our findings, the
serum PCT cut-off values with the greatest specificity
should routinely be 2 ng/mL. However, for a PCT cut-off
value >2 ng/mL, the lower sensitivity may miss some cir-
rhotic patients with infections who should undergo early
empirically based antibiotic treatment. Peripheral WBC
is the most convenient diagnostic biomarker of infec-
tions, but it is often complicated by splenomegaly and
hypersplenism in cirrhotic patients, so the WBC count
was normally significantly lower. The study also found
that in peripheral blood, WBC ≥10 × 109/L and WBC/
PLT ≥0.25 could be used for the diagnosis of cirrhoticwith WBC/PLT ratios for SBP in cirrhotic ascites patients
PCT +WBC/PLT
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100% but the sensitivity was lower (47.8% and 39.6%, re-
spectively). Thus, based on our findings, the use of
serum PCT levels combined with WBC/PLT ratios can
significantly improve the sensitivity of the early diagnosis
of liver cirrhosis with infections.
In this study, we also found that in DCP with SBP,
serum PCT levels, WBC, and WBC/PLT ratios were not
significantly different between ascites culture-positive
and -negative patients. Serum PCT levels combined with
WBC/PLT ratios was an early biomarker for the diagnosis
of SBP, and the sensitivity and specificity were 83.6% and
94.2%, respectively. Based on rapid detection within 2 h,
bedside availability and the non-invasiveness of the diag-
nostic examination, serum PCT levels appear to have
many advantages over the traditional PMN count in AF
for the early diagnosis of SBP, especially in the absence of
another site of infection. It is strongly recommended for
use in clinical practice for the early diagnosis of SBP in cir-
rhotic patients with ascites.
In conclusion, serum PCT levels along with WBC/PLT ra-
tios can be used as diagnostic biomarkers of cirrhotic pa-
tients with infections. Serum PCT levels should be
considered in combination with WBC/PLT ratios or AF
leukocyte counts, which can significantly improve sensitivity
for the early diagnosis of SBP. Without a doubt, a prospect-
ive, randomized multicenter studies are needed to confirm
the early diagnostic value of serum PCT levels alone or in
combination with WBC/PLT ratios or AF leukocyte counts
and to guide empirically based antibiotic administration.
Conclusions
From this study, we can conclude that serum PCT levels
alone or in combination with WBC/PLT measurements
seem to provide a satisfactory early diagnostic biomarker
in DCPs with infections, especially for patients with SBP.
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